Fierce Biotech
Phage-focused BiomX resets after adverse events derail pipeline, considers pivot to defense sector
Phage-focused BiomX is undergoing a “strategic and financial reset” in efforts to improve the biotech’s financial position, mapping out a possible shift from therapeutics to the defense sector.